Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

JS Zifodya, I Schiller, N Dendukuri… - Cochrane Database …, 2019 - cochranelibrary.com
Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

[HTML][HTML] Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers …

RD Kanabalan, LJ Lee, TY Lee, PP Chong… - Microbiological …, 2021 - Elsevier
Mycobacterium tuberculosis complex (MTBC) refers to a group of mycobacteria
encompassing nine members of closely related species that causes tuberculosis in animals …

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

JS Zifodya, JS Kreniske, I Schiller… - Cochrane Database …, 2021 - cochranelibrary.com
Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial

HS Cox, S Mbhele, N Mohess, A Whitelaw… - PLoS …, 2014 - journals.plos.org
Background Xpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-
resistance diagnosis. However, data are limited on the impact of Xpert under routine …

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial

B Durovni, V Saraceni, S van den Hof, A Trajman… - PLoS …, 2014 - journals.plos.org
Background Abundant evidence on Xpert MTB/RIF accuracy for diagnosing tuberculosis
(TB) and rifampicin resistance has been produced, yet there are few data on the population …

Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects

YK Yong, HY Tan, A Saeidi, WF Wong… - Frontiers in …, 2019 - frontiersin.org
Tuberculosis (TB) treatment monitoring is paramount to clinical decision-making and the
host biomarkers appears to play a significant role. The currently available diagnostic …

Xpert MTB/RIF assay as a substitute for smear microscopy in an intermediate-burden setting

HS Lee, SJ Kee, JH Shin, YS Kwon, S Chun… - American journal of …, 2019 - atsjournals.org
Rationale: Use of Xpert MTB/RIF assay as a substitute for smear microscopy in routine
clinical practice remains unexplored in an intermediate-tuberculosis-burden setting …

[PDF][PDF] Diagnostic yield of bronchoalveolar lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis

KF Khalil, T Butt - J Coll Physicians Surg Pak, 2015 - jcpsp.pk
Objective: To measure the diagnostic yield of Bronchoalveolar Lavage (BAL) gene Xpert
(Xpert MTB/RIF assay), to detect Mycobacterium tuberculosis (MTB) and rifampicin …

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis

K Zong, C Luo, H Zhou, Y Jiang, S Li - BMC microbiology, 2019 - Springer
Background To estimate the diagnostic accuracy of Xpert MTB/RIF for rifampicin resistance
in different regions, a meta-analysis was carried out. Methods Several databases were …

Cost and affordability of scaling up tuberculosis diagnosis using Xpert MTB/RIF testing in West Java, Indonesia

M Nadjib, RK Dewi, E Setiawan, TY Miko, S Putri… - PLoS …, 2022 - journals.plos.org
In Indonesia, a significant number of tuberculosis (TB) cases may be missed, due to the low
sensitivity and specificity of the currently used diagnostic algorithm. In this regard, the rapid …